NCT06780670 2026-03-16
PSMAcTION
Novartis
Phase 2/3 Recruiting
Clinical Trials
8 trialsNCT03258320 2026-01-12
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Recruiting
NCT03701581 2025-12-17
4-aminopyridine Treatment for Nerve Injury
University of Arizona
Phase 2/3 Recruiting
NCT07209878 2025-10-07
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
First Affiliated Hospital of Fujian Medical University
Phase 2/3 Recruiting
NCT05381103 2025-01-31
PSMA-PET to Guide Prostatectomy
Five Eleven Pharma, Inc.
Phase 2/3 Recruiting
NCT06282588 2024-02-28
THUNDER
Cancer Research Antwerp
Phase 2/3 Recruiting
NCT04242017 2023-12-13
LOBSTER
Universitaire Ziekenhuizen KU Leuven
Phase 2/3 Recruiting
NCT04654338 2023-06-27
EARTH
Sunnybrook Health Sciences Centre
Phase 2/3 Recruiting